ISS A/S
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
435 disclosures on record
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 27, 2026 | Marshall Wace LLP | 0.48% | February 27, 2026 |
| January 16, 2026 | Marshall Wace LLP | 0.50% | January 16, 2026 |
| January 12, 2026 | Marshall Wace LLP | 0.49% | January 12, 2026 |
| January 5, 2026 | Marshall Wace LLP | 0.59% | January 5, 2026 |
| December 16, 2025 | Marshall Wace LLP | 0.60% | December 16, 2025 |
| December 11, 2025 | Marshall Wace LLP | 0.59% | December 11, 2025 |
| December 10, 2025 | Marshall Wace LLP | 0.61% | December 10, 2025 |
| December 9, 2025 | Fosse Capital Partners LLP | 0.46% | December 9, 2025 |
| December 5, 2025 | Fosse Capital Partners LLP | 0.59% | December 5, 2025 |
| December 2, 2025 | Fosse Capital Partners LLP | 0.66% | December 2, 2025 |
| December 2, 2025 | Marshall Wace LLP | 0.52% | December 2, 2025 |
| December 1, 2025 | Marshall Wace LLP | 0.69% | December 1, 2025 |
| November 5, 2025 | AKO Capital LLP | 0.49% | November 5, 2025 |
| October 31, 2025 | Marshall Wace LLP | 0.71% | October 31, 2025 |
| October 16, 2025 | Marshall Wace LLP | 0.69% | October 16, 2025 |
| October 16, 2025 | AKO Capital LLP | 0.57% | October 16, 2025 |
| October 2, 2025 | Marshall Wace LLP | 0.79% | October 2, 2025 |
| September 26, 2025 | Marshall Wace LLP | 0.80% | September 26, 2025 |
| September 17, 2025 | Marshall Wace LLP | 0.70% | September 17, 2025 |
| September 10, 2025 | Kintbury Capital LLP | 0.25% | September 10, 2025 |
| September 5, 2025 | AKO Capital LLP | 0.68% | September 5, 2025 |
| September 2, 2025 | Marshall Wace LLP | 0.60% | September 2, 2025 |
| August 21, 2025 | Kintbury Capital LLP | 0.79% | August 21, 2025 |
| August 14, 2025 | AKO Capital LLP | 0.79% | August 14, 2025 |
| August 13, 2025 | AKO Capital LLP | 0.84% | August 13, 2025 |
| July 28, 2025 | Kintbury Capital LLP | 0.87% | July 28, 2025 |
| July 28, 2025 | Fosse Capital Partners LLP | 0.77% | July 28, 2025 |
| June 25, 2025 | Marshall Wace LLP | 0.52% | June 25, 2025 |
| June 19, 2025 | Marshall Wace LLP | 0.49% | June 19, 2025 |
| June 18, 2025 | Marshall Wace LLP | 0.50% | June 18, 2025 |
| June 16, 2025 | Marshall Wace LLP | 0.48% | June 16, 2025 |
| June 10, 2025 | Marshall Wace LLP | 0.50% | June 10, 2025 |
| May 22, 2025 | AKO Capital LLP | 0.92% | May 22, 2025 |
| May 20, 2025 | Kintbury Capital LLP | 0.93% | May 20, 2025 |
| May 13, 2025 | Fosse Capital Partners LLP | 0.81% | May 13, 2025 |
| May 2, 2025 | Kintbury Capital LLP | 0.79% | May 2, 2025 |
| May 1, 2025 | Balyasny Asset Management (UK) LLP | 0.49% | May 1, 2025 |
| April 7, 2025 | AKO Capital LLP | 1.12% | April 7, 2025 |
| April 4, 2025 | AKO Capital LLP | 1.24% | April 4, 2025 |
| March 21, 2025 | Kintbury Capital LLP | 0.88% | March 21, 2025 |
| March 20, 2025 | Kintbury Capital LLP | 0.91% | March 20, 2025 |
| March 19, 2025 | Balyasny Asset Management (UK) LLP | 0.58% | March 19, 2025 |
| March 17, 2025 | Balyasny Asset Management (UK) LLP | 0.60% | March 17, 2025 |
| March 14, 2025 | Balyasny Asset Management (UK) LLP | 0.59% | March 14, 2025 |
| March 11, 2025 | Kintbury Capital LLP | 0.89% | March 11, 2025 |
| March 6, 2025 | Balyasny Asset Management (UK) LLP | 0.69% | March 6, 2025 |
| March 6, 2025 | Shadowfall Capital & Research LLP | 0.43% | March 6, 2025 |
| March 4, 2025 | Shadowfall Capital & Research LLP | 0.50% | March 4, 2025 |
| February 27, 2025 | Balyasny Asset Management (UK) LLP | 0.79% | February 27, 2025 |
| February 21, 2025 | Balyasny Asset Management (UK) LLP | 0.81% | February 21, 2025 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, ISS A/S, source Finanstilsynet, data as at February 27, 2026, https://www.quivad.com/action/iss-a-s